CoChat
Cited by 278

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel

Open access
Adams, Emily R., Ainsworth, Mark, Anand, Rekha, Andersson, Monique I., Auckland, Kathryn, Baillie, J. Kenneth, Barnes, Eleanor, Beer, Sally, Bell, John I., Berry, Tamsin, Bibi, Sagida, Carroll, Miles, Chinnakannan, Senthil K., Clutterbuck, Elizabeth, Cornall, Richard J., Crook, Derrick W., de Silva, Thushan, Dejnirattisai, Wanwisa, Dingle, Kate E., Dold, Christina, Espinosa, Alexis, Eyre, David W., Farmer, Helen, Fernandez Mendoza, Maria, Georgiou, Dominique, Hoosdally, Sarah J., Hunter, Alastair, Jefferey, Katie, Kelly, Dominic F., Klenerman, Paul, Knight, Julian, Knowles, Clarice, Kwok, Andrew J., Leuschner, Ullrich, Levin, Robert, Liu, Chang, López-Camacho, César, Martinez, Jose, Matthews, Philippa C., McGivern, Hannah, Mentzer, Alexander J., Milton, Jonathan, Mongkolsapaya, Juthathip, Moore, Shona C., Oliveira, Marta S., Pereira, Fiona, Perez, Elena, Peto, Timothy, Ploeg, Rutger J., Pollard, Andrew, Prince, Tessa, Roberts, David J., Rudkin, Justine K., Sanchez, Veronica, Screaton, Gavin R., Semple, Malcolm G., Slon-Campos, Jose, Skelly, Donal T., Smith, Elliot Nathan, Sobrinodiaz, Alberto, Staves, Julie, Stuart, David I., Supasa, Piyada, Surik, Tomas, Thraves, Hannah, Tsang, Pat, Turtle, Lance, Walker, A. Sarah, Wang, Beibei, Washington, Charlotte, Watkins, Nicholas, Whitehouse, James, National COVID Testing Scientific Advisory Panel · 2020 · Wellcome Open Research

Published version of a preprint

Abstract

Background: The COVID-19 pandemic caused >1 million infections during January-March 2020. There is an urgent need for reliable antibody detection approaches to support diagnosis, vaccine development, safe release of individuals from quarantine, and population lock-down exit strategies. We set out to evaluate the performance of ELISA and lateral flow immunoassay (LFIA) devices. Methods: We tested plasma for COVID (severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) IgM and IgG antibodies by ELISA and using nine different LFIA devices. We used a panel of plasma samples from individuals who have had confirmed COVID infection based on a PCR result (n=40), and pre-pandemic negative control samples banked in the UK prior to December-2019 (n=142). Results: ELISA detected IgM or IgG in 34/40 individuals with a confirmed history of COVID infection (sensitivity 85%, 95%CI 70-94%), vs. 0/50 pre-pandemic controls (specificity 100% [95%CI 93-100%]). IgG levels were detected in 31/31 COVID-positive individuals tested ≥10 days after symptom onset (sensitivity 100%, 95%CI 89-100%). IgG titres rose during the 3 weeks post symptom onset and began to fall by 8 weeks, but remained above the detection threshold. Point estimates for the sensitivity of LFIA devices ranged from 55-70% versus RT-PCR and 65-85% versus ELISA, with specificity 95-100% and 93-100% respectively. Within the limits of the study size, the performance of most LFIA devices was similar. Conclusions: Currently available commercial LFIA devices do not perform sufficiently well for individual patient applications. However, ELISA can be calibrated to be specific for detecting and quantifying SARS-CoV-2 IgM and IgG and is highly sensitive for IgG from 10 days following first symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.12688/wellcomeopenres.15927.1

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. P Wikramaratna, 2020, Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR., MedRxiv., 10.1101/2020.04.05.20053355 · DOI
  2. K Auckland, 2020, Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel [Supporting Data]., Figshare.
  3. J Whitman, 2020, Test performance evaluation of SARS-CoV-2 serological assays., MedRxiv., 10.1101/2020.04.25.20074856 · DOI

Cited by

See all 278

Metadata

Authors
Adams, E. R., Ainsworth, M., Anand, R., Andersson, M. I., Auckland, K., Baillie, J. K., Barnes, E., Beer, S., Bell, J. I., Berry, T., Bibi, S., Carroll, M., Chinnakannan, S. K., Clutterbuck, E., Cornall, R. J., Crook, D. W., de Silva, T., Dejnirattisai, W., Dingle, K. E., Dold, C., Espinosa, A., Eyre, D. W., Farmer, H., Fernandez Mendoza, M., Georgiou, D., Hoosdally, S. J., Hunter, A., Jefferey, K., Kelly, D. F., Klenerman, P., Knight, J., Knowles, C., Kwok, A. J., Leuschner, U., Levin, R., Liu, C., López-Camacho, C., Martinez, J., Matthews, P. C., McGivern, H., Mentzer, A. J., Milton, J., Mongkolsapaya, J., Moore, S. C., Oliveira, M. S., Pereira, F., Perez, E., Peto, T., Ploeg, R. J., Pollard, A., Prince, T., Roberts, D. J., Rudkin, J. K., Sanchez, V., Screaton, G. R., Semple, M. G., Slon-Campos, J., Skelly, D. T., Smith, E. N., Sobrinodiaz, A., Staves, J., Stuart, D. I., Supasa, P., Surik, T., Thraves, H., Tsang, P., Turtle, L., Walker, A. S., Wang, B., Washington, C., Watkins, N., Whitehouse, J., & Panel, N. C. T. S. A.
Venue
Wellcome Open Research
Published
2020-06-11
Volume
5
Pages
139
ISSN
2398-502X (ISSN-L)
OpenAlex
W3034957268
Cited by
278
References
24
FWCI
7.91
Type
journal article
Language
en
Open access
gold
Licence
creativecommons.org/licenses/by/4.0/ (tdm)
Funders
  • NIHR Oxford Biomedical Research Centre
  • National Institute for Health Research (CO-CIN-01, NIHR200907)
  • Public Health England
  • NIHR Health Protection Research Unit in Emerging and Zoonotic Infections
  • UK Government Department of Health and Social Care
  • National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance
  • Wellcome Trust (095541, 110110, 109965, 110058)
  • Medical Research Council (MC_PC_1905)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.